Hippocampal volume in young adults with moderate to severe depression before and after combined antidepressant therapy
This historical record does not confirm current site availability.
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
Who could participate?
This study is for people with depression. Other eligibility criteria apply.
- Listed locations
- Germany
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
This is historical registry information. What is the current study status and protocol?
Things to check before joining
- Recruitment status
- Recruitment unclear
- Enrollment listed in the registry
- 160
- Sponsor
- Department of Psychiatry and Psychotherapy, University of Erlangen-Nuremberg
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Germany
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2004-002788-25
- Official title
Show the full official title
Hippocampal volume in young adults with moderate to severe depression before and after combined antidepressant therapy
Recruitment & locations
Status unknownGermany
Registry details
- Germany — Ongoing
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Department of Psychiatry and Psychotherapy, University of Erlangen-Nuremberg, a university.
Who can participate?
This study is for people with depression. Other eligibility criteria apply.
